Edward M. MD Kaye

CIK 1522780 · CEO · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.20M

Companies

6

Total Filings

116

Lifetime Open-Market Net

-$18.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STOK Director 110,874 $29.82 $3.31M -$8.05M 36 2026-06-05
CYTK Director 10,283 $70.15 $721.4K -$5.51M 50 2026-06-01
Avidity Biosciences, Inc. (RNAM) Delisted Director 0 $0 1 2026-02-27
RNA Director 6,692 $12.37 $82.8K $0 5 2025-06-12
SRPT President & CEO 71,229 $15.31 $1.09M -$4.77M 22 2017-08-07
Sarepta Therapeutics, Inc. (AVII) Delisted SVP & Chief Medical Officer $0 2 2012-04-25

Recent Filings · Page 2 of 12

116 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-02 CYTK Mixed -$1.49M EDGAR
2025-11-12 CYTK Mixed -$286.8K EDGAR
2025-10-16 CYTK Grant (A) +199 $12.5K EDGAR
2025-10-10 STOK Mixed -$735.0K EDGAR
2025-10-07 STOK Sell (S) −42,461 -$1.07M EDGAR
2025-10-06 CYTK Sell (S) −6,757 -$405.4K EDGAR
2025-09-30 CYTK Sell (S) −6,695 -$368.8K EDGAR
2025-09-05 STOK Disp (D) $0 EDGAR
2025-09-03 STOK Sell (S) −61,885 -$1.25M EDGAR
2025-09-02 CYTK Sell (S) −6,756 -$337.8K EDGAR
Showing 1120 of 116
Page 2 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.